REFERENCES
1. Ndumele CE, Rangaswami J, Chow SL, et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association. Circulation. 2023;148:1606-35.
2. Ndumele CE, Neeland IJ, Tuttle KR, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the american heart association. Circulation. 2023;148:1636-64.
3. Yang Q, Zhu X, Zhang L, Luo F. Dyslipidemia and aging: the non-linear association between atherogenic index of plasma (AIP) and aging acceleration. Cardiovasc Diabetol. 2025;24:181.
4. Li X, Cao X, Zhang J, et al. Accelerated aging mediates the associations of unhealthy lifestyles with cardiovascular disease, cancer, and mortality. J Am Geriatr Soc. 2024;72:181-93.
5. Hu L, Li J, Tang Z, et al. How does biological age acceleration mediate the associations of obesity with cardiovascular disease? Evidence from international multi-cohort studies. Cardiovasc Diabetol. 2025;24:209.
6. Zhang Z, He X, Sun Y, Li J, Sun J. Type 2 diabetes mellitus: a metabolic model of accelerated aging - multi-organ mechanisms and intervention approaches. Aging Dis. 2025;17:1399-422.
7. Zhang P, Mo D, Zeng W, Dai H. Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0-3: a cohort study. Cardiovasc Diabetol. 2025;24:92.
8. Kityo A, Lee SA. Association of cardiometabolic factors and insulin resistance surrogates with mortality in participants from the Korean Genome and Epidemiology Study. Lipids Health Dis. 2023;22:210.
9. Levine ME, Lu AT, Quach A, et al. An epigenetic biomarker of aging for lifespan and healthspan. Aging. 2018;10:573-91.
10. Pan LY, Jin L. Association between triglyceride glucose index and biological aging in U.S. adults: National Health and Nutrition Examination Survey. Cardiovasc Diabetol. 2025;24:100.
11. Ou Y, Wang Z, Yuan Y, et al. Epigenetic age acceleration and rheumatoid arthritis: an NHANES-based analysis and survival prediction models. Clin Epigenet. 2025;17:111.
12. Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of cardiovascular-kidney-metabolic syndrome stages in US adults, 2011-2020. JAMA. 2024;331:1858-60.
13. Zhu R, Wang R, He J, et al. Prevalence of cardiovascular-kidney-metabolic syndrome stages by social determinants of health. JAMA Netw Open. 2024;7:e2445309.
14. Boutouyrie P, Chowienczyk P, Humphrey JD, Mitchell GF. Arterial stiffness and cardiovascular risk in hypertension. Circ Res. 2021;128:864-86.
15. Wei Z, Nie G, Li J, Zhang J, Liu H, Ma M. Association of triglyceride-glucose index and its related parameters with functional disability: evidence from the China Health and Retirement Longitudinal Study. Front Aging Neurosci. 2025;17:1488124.
16. Zhang Q, Xiao S, Jiao X, Shen Y. The triglyceride-glucose index is a predictor for cardiovascular and all-cause mortality in CVD patients with diabetes or pre-diabetes: evidence from NHANES 2001-2018. Cardiovasc Diabetol. 2023;22:279.
17. Sun Y, Liu B, Snetselaar LG, et al. Association of fried food consumption with all cause, cardiovascular, and cancer mortality: prospective cohort study. BMJ. 2019;364:k5420.
18. Ashwell M, Gibson S. Waist-to-height ratio as an indicator of 'early health risk': simpler and more predictive than using a 'matrix' based on BMI and waist circumference. BMJ Open. 2016;6:e010159.
19. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13:275-86.
20. Li S, An L, Fu Z, Zhang W, Liu H. Association between triglyceride-glucose related indices and all-cause and cause-specific mortality in the general population: a cohort study. Cardiovasc Diabetol. 2024;23:286.
21. Ren Q, Huang Y, Liu Q, Chu T, Li G, Wu Z. Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study. Cardiovasc Diabetol. 2024;23:247.
22. Zhang Y, Wu J, Li T, Qu Y, Wang Y. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes. Cardiovasc Diabetol. 2025;24:52.
23. Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol. 2024;23:8.
24. Las Heras N, Lahera V. Relevance of mitochondrial dysfunction in heart disease associated with insulin resistance conditions. Pflugers Arch. 2022;474:21-31.
25. Laakso M. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010;33:442-9.
26. Gallo G, Savoia C. New insights into endothelial dysfunction in cardiometabolic diseases: potential mechanisms and clinical implications. Int J Mol Sci. 2024:25.
27. Li R, Lau WB, Ma XL. Adiponectin resistance and vascular dysfunction in the hyperlipidemic state. Acta Pharmacol Sin. 2010;31:1258-66.
28. Qiu J, Li J, Xu S, et al. Triglyceride glucose-weight-adjusted waist index as a cardiovascular mortality predictor: incremental value beyond the establishment of TyG-related indices. Cardiovasc Diabetol. 2025;24:306.
29. Hodge AM, Flicker L, O'Dea K, English DR, Giles GG. Diabetes and ageing in the melbourne collaborative cohort study (MCCS). Diabetes Res Clin Pract. 2013;100:398-403.
30. Huang Z, Liu N, Chen S, Chen Z, Wang P. Factors influencing accelerated aging in patients with type 2 diabetes mellitus and coronary heart disease. Front Endocrinol. 2024;15:1416234.
31. Zhang Y, Song K, Yao Z. The association between the triglyceride-glucose index and serum anti-aging protein α- Klotho: a population-based study. Diabetol Metab Syndr. 2024;16:259.
32. Oblak L, van der Zaag J, Higgins-Chen AT, Levine ME, Boks MP. A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration. Ageing Res Rev. 2021;69:101348.
33. Zhang Y, Tu J, Li Y, et al. Inflammation macrophages contribute to cardiac homeostasis. Cardiology Plus. 2023;8:6-17.
34. Lin J, Epel E. Stress and telomere shortening: insights from cellular mechanisms. Ageing Res Rev. 2022;73:101507.
35. Park MH, Kim DH, Lee EK, et al. Age-related inflammation and insulin resistance: a review of their intricate interdependency. Arch Pharmacal Res. 2014;37:1507-14.
36. Zhao Z, Liang Y. Association between triglyceride-glucose index and phenotypic age acceleration: a cross-sectional study based on NHANES database. Front Physiol. 2025;16:1548690.
37. Yan Z, Pu X, Cai Y, Chang X, Liu Z, Liu R. Biological aging traits mediate the association between cardiovascular health levels and all-cause and cardiovascular mortality among adults in the U.S. without cardiovascular disease. Biogerontology. 2025;26:40.
38. Goh J, Wong E, Soh J, Maier AB, Kennedy BK. Targeting the molecular & cellular pillars of human aging with exercise. FEBS J. 2023;290:649-68.
39. Magliano DJ, Sacre JW, Harding JL, Gregg EW, Zimmet PZ, Shaw JE. Young-onset type 2 diabetes mellitus - implications for morbidity and mortality. Nat Rev Endocrinol. 2020;16:321-31.
40. Wang C, Yuan Y, Zheng M, et al. Association of age of onset of hypertension with cardiovascular diseases and mortality. J Am Coll Cardiol. 2020;75:2921-30.
41. Vivante A, Hildebrandt F. Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol. 2016;12:133-46.
42. Tromp J, Paniagua SMA, Lau ES, et al. Age dependent associations of risk factors with heart failure: pooled population based cohort study. BMJ. 2021;372:n461.
